lobbying_activities: 2678370

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2678370	dfe21078-f0e5-4971-9dd4-91e2dfbbf059	Q3	AMERICAN UROLOGICAL ASSOCIATION	90352	AMERICAN UROLOGICAL ASSOCIATION	2021	third_quarter	MMM	Reduce regulatory burdens (e.g., MACRA implementation, prior authorizations, step-therapy) and promote practice sustainability during the COVID-19 public health emergency and beyond; Advocate to expand access to telehealth services as an alternative health care delivery model in urology to address access to care and health care equity; Preserve the appropriate use of the in-office ancillary services exception (IOASE) to the Stark Law; Advocate for the full continuum of care for prostate cancer survivorship;	HOUSE OF REPRESENTATIVES,SENATE		56000	0	0	2021-10-12T11:50:03.320000-04:00